Abstract
Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Current Drug Targets
Title: Exploring and Exploiting Biologically Relevant Chemical Space
Volume: 12 Issue: 11
Author(s): Luc Eberhardt, Kamal Kumar and Herbert Waldmann
Affiliation:
Keywords: Natural products, diversity oriented synthesis, biology oriented synthesis, compound libraries, small molecules, drug discovery, bioactivity, protein inhibitor, cyclopeptides, chemical space
Abstract: Small bioactive molecules are pre-requisite for any discovery discipline. Being aware of the fact that bioactivity is not randomly dispersed in the vast chemical space, chemists have been developing hypothesis that can provide access to these islands of bioactivities. Natural products have always been a source of inspiration and their structural motifs provide biologically relevant starting points for library synthesis. In addition to that, Diversity Oriented Synthesis (DOS) and Biology Oriented Synthesis (BIOS) have emerged other tools to guide synthesis design and help enrich compound collections in biological activities. Coherent developments in chem- and bioinformatic tools and in organic synthesis methods targeting efficient synthesis of compound collections are required to identify interesting molecules that can be employed as probes in chemical biology research and as drug candidates in medicinal chemistry investigations.
Export Options
About this article
Cite this article as:
Eberhardt Luc, Kumar Kamal and Waldmann Herbert, Exploring and Exploiting Biologically Relevant Chemical Space, Current Drug Targets 2011; 12(11) . https://dx.doi.org/10.2174/138945011798109482
DOI https://dx.doi.org/10.2174/138945011798109482 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phenothiazine Derivatives as Potential Antiproliferative Agents: A Mini-
Review
Mini-Reviews in Organic Chemistry Clinical Experience with Antiangiogenic Therapy in Leukemia
Current Cancer Drug Targets Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology PDE-5 Inhibitors for BPH-Associated LUTS
Current Drug Targets Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies
Current Pharmaceutical Design 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs)
Current Medicinal Chemistry Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Current Drug Targets Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy
Current Signal Transduction Therapy Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond
Current Medicinal Chemistry Structure-Based Drug Design to Overcome Drug Resistance: Challenges and Opportunities
Current Pharmaceutical Design Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?
Recent Patents on Anti-Cancer Drug Discovery Microwave-assisted Cycloaddition Reactions in Carbo- and Heterocyclic Chemistry
Current Organic Chemistry White Poplar (Populus alba L.) Suspension Cultures as a Model System to Study Apoptosis Induced by Alfalfa Saponins
Anti-Cancer Agents in Medicinal Chemistry Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy
Current Medicinal Chemistry Studies on Chloride Channels and their Modulators
Current Topics in Medicinal Chemistry Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines
Current Drug Metabolism Zebrafish As a Genetic Model in Pre-Clinical Drug Testing and Screening
Current Medicinal Chemistry